XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.19.1

ACQUISITIONS | 3 Months Ended
--- | ---
Mar. 31, 2019
ACQUISITIONS | NOTE C —ACQUISITION On December 22, 2017, the Company entered into an agreement providing for the acquisition of Filament by the Company. The acquisition was completed on March 2, 2018. The aggregate consideration for Filament, after taking into account certain adjustments, was $294.4 million, consisting of $217.5 million of cash consideration and 5,593,116 newly issued shares of the Company’s common stock, with a value equal to $76.9 million based on the market value of the Company’s common stock as of March 2, 2018. The cash portion of the consideration was revised for certain adjustments as defined in the agreement. The purchase price has been determined to be as follows (in thousands):
Cash |  | $ | 217,511 |
Share consideration |  |  | 76,905 |
Total purchase price |  | $ | 294,416 |
The purchase price was allocated based on the Company’s final estimate of the fair value of the assets acquired and liabilities assumed, as follows (in thousands):
Accounts receivable |  | $ | 26,224 |
Inventory |  |  | 29,044 |
Other assets |  |  | 5,620 |
Other liabilities |  |  | (23,018 | )
Deferred income tax |  |  | (13,881 | )
Goodwill and other intangibles |  |  | 270,427 |
Total allocated value |  | $ | 294,416 |
Goodwill results from such factors as an assembled workforce. The total amount of goodwill is not expected to be deductible for tax purposes. The goodwill and other intangible assets are primarily included in the U.S. segment. Customer relationships are amortized on a straight-line basis over their estimated useful lives (see Note F). The three months ended March 31, 2018 included the operations of Filament for the period from March 2, 2018, the date of acquisition, to March 31, 2018. The condensed consolidated statements of operations for the three months ended March 31, 2018 includes $9.3 million of net sales and $ 1.1 million of net loss from operations contributed by Filament. Unaudited Pro forma Results The following table presents the Company’s pro forma consolidated net sales, loss before income taxes and equity in earnings, and net loss for the three months ended March 31, 2018. The unaudited pro forma results include the historical statement of operations information of the Company and of Filament, giving effect to the Filament acquisition and related financing as if they had occurred at the beginning of the period presented.
|  | Three Months Ended |
|  | March 31, 2018 (in thousands, except per share data) |
Net sales |  | $ | 143,980 |
Loss before income taxes and equity in earnings |  |  | (15,844 | )
Net loss |  |  | (11,868 | )
Basic and diluted loss per common share |  |  | (0.58 | )
The unaudited pro forma results do not include any revenue or cost reductions that may be achieved through the business combination, or the impact of non-recurring items directly related to the business combination. The unaudited pro forma results are not necessarily indicative of the operating results that would have occurred if the Filament acquisition had been completed as of the date for which the pro forma financial information is presented. In addition, the unaudited pro forma results do not purport to project the future condensed consolidated operating results of the combined company.

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -URI http://asc.fasb.org/topic&trid=2303972 + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration